Among others, they investigated the in vivo and ex vivo biodistribution pattern and the tumour-targeting capability of 44Sc- and 68Ga-labelled B28110 ([44Sc]Sc-B28110 and [68Ga]Ga-B28110) by performing dynamic (0–90 min) and 20 min-long static (150 min post tracer injection) in vivo PET/MRI examinations in male CB17 SCID mice bearing PSMA-positive LNCaP tumours. The gene discussed is FOLH1; the disease is neoplasm.